|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646758707 |
003 |
OCoLC |
005 |
20231117033251.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
080801s1968 nyu ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d N$T
|d IDEBK
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBSZ
|d LEAUB
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 298067390
|
020 |
|
|
|a 9780080566092
|q (electronic bk.)
|
020 |
|
|
|a 008056609X
|q (electronic bk.)
|
020 |
|
|
|a 0120103117
|q (electronic bk.)
|
020 |
|
|
|a 9780120103119
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)646758707
|z (OCoLC)298067390
|
050 |
|
4 |
|a RB1
|b .A211 1968eb
|
060 |
|
4 |
|a QY 90 A244 v.11 1968
|
072 |
|
7 |
|a SCI
|x 013020
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.07/56
|2 22
|
245 |
0 |
0 |
|a Advances in clinical chemistry.
|n Volume 11 /
|c edited by Oscar Bodansky, C.P. Stewart.
|
260 |
|
|
|a New York ;
|a London :
|b Academic Press,
|c 1968.
|
300 |
|
|
|a 1 online resource (xviii, 356 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in clinical chemistry ;
|v v. 11
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover -- Advances in Clinical Chemistry, Volume 11 -- Copyright Page -- Contents -- List of Contributors -- Preface -- Contents of Previous Volumes -- Chapter 1. Enzymatic Defects in the Sphingolipidoses -- 1. Introduction -- 2. Gaucher's Disease -- 3. Metachromatic Leukodystrophy -- 4. Fabry's Disease -- 5. Niemann-Pick Disease -- 6. Tay-Sachs Disease -- 7. Generalized Gangliosidosis -- 8. Potentially Related Sphingolipodystrophies -- 9. Concluding Remarks -- References -- Chapter 2. Genetically Determined Polymorphisms of Erythrocyte Enzymes in Man -- 1. Introduction.
|
505 |
8 |
|
|a 2. Intracellular Hydrogen-Ion Concentration -- 3. pH-Sensitivc Glass Microelectrodes -- 4. Mean Whole-Body Hydrogen-Ion Concentration Using DMO -- 5. Heterogeneity of the Intracellular Fluid -- 6. Hydrogen-Ion Concentration of Individual Tissues -- References -- Chapter 7. 5'-Nucleotidase -- 1. Introduction and Historical Review -- 2. Sources and Distribution of 5'-Nucleotidase -- 3. Intracellular Localization of 5'-Nucleotidase -- 4. Purification of 5'-Nucleotidase from Various Sourccs -- 5. Kinetics of 5'-Nucleotidase -- 6. Physiologicval Role of 5'-Nucleotidase -- 7. Serum 5'-Nucleotidase.
|
505 |
8 |
|
|a 2. Red Cell Acid Phosphatase -- 3. Phosphoglucomutase -- 4. Glucose-6-phosphate Dehydrogenase -- 5. Phosphogluconate Dehydrogenase -- 6. Adenylate Kinase -- 7. Peptidases -- 8. Adenosine Deaminase -- 9. Rare Variants -- 10. Discussion -- References -- Chapter 3. Biochemistry of Functional Neural Crest Tumors -- 1. Introduction -- 2. Methods -- 3. Types of Functional Neural Crest Tumors -- 4. Biochemistry of the Pheochromocyte -- 5. Biochemistry of Pheochromocytoma -- 6. Biochemistry of Pheochromoblastoma (Malignant Pheochromocytoma) -- 7. Biochemistry of the Glomic Tissue and Glomic Neoplasia.
|
505 |
8 |
|
|a 8. Acquired Cutaneous Hepatic Porphyria -- 9. Experimental Porphyria and Biochemical Pathogenesis of the Porphyrias -- References -- Chapter 5. Premortal Clinical Biochemical Changes -- 1. Introduction -- 2. Assays of Plasma and Blood in Human Subjects -- 3. Blood Changes Before and During the Premortal Stage -- 4. Experimental Animal Studies -- 5. Biochemical Factors Directly Responsible for Causation of Death -- 6. Clinical and Therapeutic Significance of Premortal Laboratory Tests -- 7. Discussion -- References -- Chapter 6. lntracellular pH -- 1. Introduction.
|
505 |
8 |
|
|a 8. Biochemistry of the Sympathocyte (Mature Sympathetic Ganglion Cell) -- 9. Biochemistry of Sympathocytoma (Ganglioneuroma) -- 10. Biochemistry of Sympathoblastoma and Sympathogonioma (Neuroblastoma) -- 11. General Conclusion -- References -- Chapter 4. Biochemical and Clinical Aspects of the Porphyrias -- 1. Heme Biosynthesis -- 2. Normal Excretion of Porphyrins -- 3. Classification of the Porphyrias -- 4. Congenital Erythropoietic Porphyria -- 5. Congenital Erythropoietic Protoporphyria -- 6. Acute Intermittent Porphyria -- 7. Congenital Cutaneous Hepatic Porphyria.
|
520 |
|
|
|a ADVANCES IN CLINICAL CHEMISTRY VOL 11.
|
650 |
|
0 |
|a Metabolism
|x Disorders.
|
650 |
|
0 |
|a Enzymatic analysis.
|
650 |
|
2 |
|a Metabolic Diseases
|0 (DNLM)D008659
|
650 |
|
6 |
|a Troubles du m�etabolisme.
|0 (CaQQLa)201-0061163
|
650 |
|
6 |
|a Analyse enzymatique.
|0 (CaQQLa)201-0033454
|
650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Clinical.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Enzymatic analysis
|2 fast
|0 (OCoLC)fst00913593
|
650 |
|
7 |
|a Metabolism
|x Disorders
|2 fast
|0 (OCoLC)fst01017476
|
700 |
1 |
|
|a Bodansky, Oscar,
|d 1901-1977.
|
700 |
1 |
|
|a Stewart, C. P.
|q (Corbet Page)
|
776 |
0 |
8 |
|i Print version:
|t Advances in clinical chemistry. Volume 11.
|d New York ; London : Academic Press, 1968
|w (DLC) 58012341
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120103119
|z Texto completo
|